Peptides9 min read
Hexarelin and the heart: what brief changes in pumping can tell us
Brief improvements in heart pumping are not the same as preventing heart attacks. Examine the small human hexarelin studies and their clinical limits.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Peptides articles
All articlesMetabolism, recovery and emerging research
Peptides9 min read
Cibinetide and erythropoietin: a related design with a different aim
Cibinetide's connection to erythropoietin explains its design, not an established clinical benefit. The distinction between red-cell production and tissue-protection research helps make sense of the evidence.
Read article
Peptides8 min read
Why ipamorelin and CJC-1295 are paired, and what is still untested
Two pituitary signals explain the combination’s rationale. The exact CJC-1295 form, the outcomes measured, and the absence of a direct benefit comparison matter.
Read article
Peptides9 min read
Can amylin research tell us who will respond best?
Amylin biology and trial averages can guide research, but personalized response claims require separate validation in new patients.
Read article
Peptides8 min read
Reading a human hexarelin study: what the original experiments actually tested
A close reading of the original hexarelin experiments explains what small human studies measured and where claims about lasting benefits go beyond the results.
Read article
Peptides9 min read
How to read an ARA-290 study without turning a promising signal into a cure
Use real ARA-290 studies to distinguish nerve images, symptom relief, glucose results, retinal outcomes and laboratory brain responses.
Read article
Peptides9 min read
What would useful IGF-1 LR3 clinical research need to measure?
Useful LR3 research would need to connect a defined exposure to meaningful strength or recovery outcomes while systematically measuring harms.
Read article
Peptides9 min read
What a stronger Selank clinical trial would need to improve
A useful next Selank trial needs a defined product, a focused patient group, meaningful outcomes and follow-up that includes people who stop treatment.
Read article
Peptides9 min read
Humanin and insulin sensitivity: what the metabolic studies show
Humanin’s metabolic evidence spans rodent insulin-action experiments, beta-cell models and human blood associations. Each answers a different question.
Read article
Peptides8 min read
Does a growth-hormone pulse predict GHRP-6 recovery benefits?
Human studies show GHRP-6 hormone responses, but those measurements do not establish faster healing. Explore GH, IGF-1 and functional recovery.
Read article
Peptides9 min read
Hexarelin and muscle strength: what human studies actually measured
Hexarelin releases growth hormone, but the human research has not established stronger muscles. See what the studies measured and why lean mass can mislead.
Read article
Peptides9 min read
PEG-MGF stacks: how several untested links compound uncertainty
Why separate mechanisms, exercise-expression studies and personal reports cannot establish synergy, timing or safety for a PEG-MGF combination.
Read article301–312 of 323 articles